TABLE 1.
Patient | Gender | Age (years) | β-blocking Drug | QTc (ms) | QTc leaving 90% of control QTc below (ms) | QTc increment (%) |
---|---|---|---|---|---|---|
1 | Male | 1 | Nadolol | 542 | 434 | 24.9 |
(7 months) | 516 | 434 | 18.9 | |||
2 | Female | 29 | Nadolol | 503 | 437 | 15.1 |
498 | 437 | 14.0 | ||||
3 | Female | 11 | Nadolol | 555 | 434 | 27.9 |
528 | 434 | 21.7 | ||||
4 | Female | 2 | Propranolol | 471 | 434 | 8.5 |
556 | 434 | 28.1 | ||||
Average | 19.9 |
This table contains anonymized relevant data of our four patients (from 1 to 4), namely, from left to right, their assigned code, gender, age (in years), the name of the administered β-blocking drug, registered QTc interval values (in ms), reference QTc values (in ms) and calculated QTc increment (in %). The last row shows the average QTc increment.